Microsoft's Collaboration with Scientists to use AI for Delivering Medicines Faster

It is no doubt that Microsoft keeps evolving with the advancement in technology and this project can be a breakthrough for the upcoming world.

This project can easily take a decade and can cost a billion. Apart from the cost and expenditure, this project emphasizes taking a big revolutionary take for the new world which is backed by AI and other tools for Web3.0.

Scientists at Novartis are searching for various ways in which they can suitably serve medicines to the patients as faster as possible using the help of AI.

This scenario is perfectly described by Luca Finelli, in which he described this in a Snackable way, he said that the chefs are the chemists, the ingredients are the molecules, and the main course in the new medication to defeat the illness.

“Creating the formulation to a drug is a bit like cooking,” says Finelli, vice president and head of insights, strategy, and design at Novartis, a multinational pharmaceutical company headquartered in Basel, Switzerland.

On the same side, scientists also believe that it is a tedious process as it requires a various blend of molecules to kid in order to get one effective medication, that is why it will a decade or so to bring revolution in the medicinal industry.

Furthermore, the Collaboration of Microsoft and the ultimate leveraging power of AI will possibly help the scientists to reduce this process to a few weeks or so.

Talking about the process of how the scientists at Novartis, Finelli added, ' The scientists need to decide and will take the ingredient A and B, and then try several combinations out of that.

But HOW?

AI-based tools can quickly filter through massive amounts of data and findings from decades of laboratory experiments to recommend compounds with the needed properties that are most suited to the therapeutic task at hand.

Those drug candidates might then be rushed through more testing and, if found to be safe and effective, developed and manufactured as a treatment for illness.

This AI-assisted technique could save years of trial-and-error experimenting with less-than-ideal molecules.

Look what Shahram Ebadollahi(chief data and AI officer at Novartis) has to say about this revolutionary project.

Democratizing access to AI

Moreover, Karin Briner, head of global discovery chemistry at Novartis Institutes of BioMedical Research, said that Novartis scientists will create a molecule that has never been made and these molecules will help in developing new medicines to tackle those illnesses for which there is no treatment available.

The lab director for Microsoft Research Europe, Chris Bishop said that two things are established by Microsoft and further added that We bring our machine learning knowledge as well as our large-scale computing capabilities that don’t exist in the pharmaceutical industry.

Furthermore, Microsoft isn't up to the task (independently). We're not a pharmaceutical firm. As a result, collaboration is critical.

Lastly, to know the detailed information about this project, and what the officials from Microsoft and Novartis said, you can check out the recent article from Microsoft.